Using a type 1 collagen-based system to understand cell-scaffold interactions and to deliver chimeric collagen-binding growth factors for vascular tissue engineering

Journal of Investigative Medicine

Volumn 58, Issue 7, 2010, Pages 845-848

  Pang, Yonggang ^a,b,c   Greisler, Howard P ^a,b,d  

^a LOYOLA UNIVERSITY   (United States)

^b HINES VA HOSPITAL   (United States)

^c Illinois Institute of Technology   (United States)

^d LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Confocal microscopy; Growth factor; Local delivery; Scaffold; Type 1 collagen

Indexed keywords

COLLAGEN BINDING PROTEIN; COLLAGEN FIBER; COLLAGEN TYPE 1; TISSUE SCAFFOLD; CHIMERIC COLLAGEN BINDING GROWTH FACTOR; GROWTH FACTOR; UNCLASSIFIED DRUG;

BIOCOMPATIBILITY; CELL INTERACTION; CELL PROLIFERATION; CELL STIMULATION; CONFERENCE PAPER; EXTRACELLULAR MATRIX; PROTEIN INTERACTION; THREE DIMENSIONAL IMAGING; TISSUE ENGINEERING; VASCULAR TISSUE; ARTICLE; BLOOD VESSEL GRAFT; CELL GROWTH; CELL VIABILITY; COLLAGEN FIBER; CONFOCAL MICROSCOPY; DRUG DELIVERY SYSTEM; FIBROBLAST; HYDROGEL; HYDROGEN BOND; IMAGE PROCESSING; IMMUNOREACTIVITY; REFLECTANCE CONFOCAL MICROSCOPY; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CELL;

EID: 78651480278     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: 10.2310/JIM.0b013e3181ee81f7     Document Type: Conference Paper

References (35)

1. Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation. 2010;121(7): e46-e215.
2. Campbell JH, Efendy JL, Campbell GR. Novel vascular graft grown within recipient's own peritoneal cavity. Circ Res. 1999;85(12):1173-1178.
3. Bader A, Steinhoff G, Strobl K, et al. Engineering of human vascular aortic tissue based on a xenogeneic starter matrix. Transplantation. 2000;70(1):7-14. (Pubitemid 30490745)
4. Xue L, Greisler HP. Biomaterials in the development and future of vascular grafts. J Vasc Surg. 2003;37(2):472-480.
5. Stegemann JP, Kaszuba SN, Rowe SL. Review: advances in vascular tissue engineering using protein-based biomaterials. Tissue Eng. 2007;13(11):2601-2613.
6. Thomas AC, Campbell GR, Campbell JH. Advances in vascular tissue engineering. Cardiovasc Pathol. 2003;12(5):271-276.
7. Griffith LG, Naughton G. Tissue engineering-current challenges and expanding opportunities. Science. 2002;295(5557):1009-1014.
8. Pang Y, Wang X, Ucuzian AA, et al. Local delivery of a collagen-binding FGF-1 chimera to smooth muscle cells in collagen scaffolds for vascular tissue engineering. Biomaterials. 2010;31(5):878-885.
9. Pang Y, Ucuzian AA, Matsumura A, et al. The temporal and spatial dynamics of microscale collagen scaffold remodeling by smooth muscle cells. Biomaterials. 2009;30(11):2023-2031.
10. Xue L, Greisler HP. Angiogenic effect of fibroblast growth factor-1 and vascular endothelial growth factor and their synergism in a novel in vitro quantitative fibrin-based 3-dimensional angiogenesis system. Surgery. 2002;132(2):259-267.
11. Tan H, Ramirez CM, Miljkovic N, et al. Thermosensitive injectable hyaluronic acid hydrogel for adipose tissue engineering. Biomaterials. 2009;30(36):6844-6853.
12. Stevens MM, Qanadilo HF, Langer R, et al. A rapid-curing alginate gel system: utility in periosteum-derived cartilage tissue engineering. Biomaterials. 2004;25(5):887-894.
13. Jiang T, Kumbar SG, Nair LS, et al. Biologically active chitosan systems for tissue engineering and regenerative medicine. Curr Top Med Chem. 2008;8(4):354-364.
14. Lee CH, Singla A, Lee Y. Biomedical applications of collagen. Int J Pharm. 2001;221(1-2): 1-22.
15. Stegemann JP, Nerem RM. Altered response of vascular smooth muscle cells to exogenous biochemical stimulation in two-and three-dimensional culture. Exp Cell Res. 2003;283(2):146-155.
16. Miller EJ, Rhodes RK. Preparation and characterization of the different types of collagen. Methods Enzymol. 1982;82(pt A): 33-64.
17. Weinberg CB, Bell E. A blood vessel model constructed from collagen and cultured vascular cells. Science. 1986;231(4736):397-400.
18. L'Heureux N, Germain L, Labbe R, et al. In vitro construction of a human blood vessel from cultured vascular cells: a morphologic study. J Vasc Surg. 1993;17(3):499-509.
19. Li S, Moon JJ, Miao H, et al. Signal transduction in matrix contraction and the migration of vascular smooth muscle cells in three-dimensional matrix. J Vasc Res. 2003;40(4):378-388.
20. Franco C, Ho B, Mulholland D, et al. Doxycycline alters vascular smooth muscle cell adhesion, migration, and reorganization of fibrillar collagen matrices. Am J Pathol. 2006;168(5):1697-1709.
21. Marks RL, Rock SM, Lee MJ. Real-time video mosaicking of the ocean floor. IEEE J Ocean Eng. 1995;20(3):229-241.
22. Loo BW Jr, Meyer-Ilse W, Rothman SS. Automatic image acquisition, calibration and montage assembly for biological x-ray microscopy. J Microsc. 2000;197(pt 2):185-201.
23. Rubin AL, Stenzel KH, Miyata T, et al. Collagen as a vehicle for drug delivery. Preliminary report. J Clin Pharmacol. 1973;13(8):309-312.
24. Friedl P, Maaser K, Klein CE, et al. Migration of highly aggressive MV3 melanoma cells in 3-dimensional collagen lattices results in local matrix reorganization and shedding of alpha2 and beta1 integrins and CD44. Cancer Res. 1997;57(10):2061-2070.
25. Brewster LP, Washington C, Brey EM, et al. Construction and characterization of a thrombin-resistant designer FGF-based collagen binding domain angiogen. Biomaterials. 2008;29(3):327-336.
26. Kay JS, Litin BS, Jones MA, et al. Delivery of antifibroblast agents as adjuncts to filtration surgery-part II: delivery of 5-fluorouracil and bleomycin in a collagen implant: pilot study in the rabbit. Ophthalmic Surg. 1986;17:796-801.
27. Phinney RB, Schwartz SD, Lee DA, et al. Collagen-shield delivery of gentamicin and vancomycin. Arch Ophthalmol. 1988;106:1599-1604.
28. Moursi AM, Winnard PL, Fryer D, et al. Delivery of transforming growth factor-beta2-perturbing antibody in a collagen vehicle inhibits cranial suture fusion in calvarial organ culture. Cleft Palate Craniofac J. 2003;40:225-232.
29. Letic-Gavrilovic A, Piattelli A, Abe K. Nerve growth factor beta (NGF beta) delivery via a collagen/hydroxyapatite (Col/HAp) composite and its effects on new bone ingrowth. J Mater Sci Mater Med. 2003;14:95-102.
30. Sun JS, Lin FH, Wang YJ, et al. Collagen-hydroxyapatite/tricalcium phosphate microspheres as a delivery system for recombinant human transforming growth factor-beta 1. Artif Organs. 2003;27:605-612.
31. Hu Y, Zhang C, Zhang S, et al. Development of a porous poly (L-lactic acid)/hydroxyapatite/collagen scaffold as a BMP delivery system and its use in healing canine segmental bone defect. J Biomed Mater Res A. 2003;67:591-598.
32. Govender S, Csimma C, Genant HK, et al. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am. 2002;84-A:2123-2134.
33. Takezawa T, Takeuchi T, Nitani A, et al. Collagen vitrigel membrane useful for paracrine assays in vitro and drug delivery systems in vivo. J Biotechnol. 2007;131:76-83.
34. Friedl P, Maaser K, Klein CE, et al. Migration of highly aggressive MV3 melanoma cells in 3-dimensional collagen lattices results in local matrix reorganization and shedding of alpha2 and beta1 integrins and CD44. Cancer Res. 1997;57:2061-2070.
35. Brewster LP, Washington C, Brey EM, et al. Construction and characterization of a thrombin-resistant designer FGF-based collagen binding domain angiogen. Biomaterials. 2008;29:327-336.